Thus, alterations in breast cancer cell cycle, especially entrance into the S phase, are responsible, in part, for the decreases in breast cancer proliferation observed when triple-negative or ER+ breast cancer cells are exposed to EO CM. This evidence concerns the gene ESR1 and breast cancer.